Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Guerra, Laura T
Dauntless-1, NCT04115306: Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer	Recruiting	1/2	61	US	PMD-026, fulvestrant, Faslodex	Phoenix Molecular Designs	Metastatic Breast Cancer	12/25	03/26
BEGIN, NCT06272864: BostonGene and Exigent Genomic INsight Study	Recruiting	N/A	400	US		BostonGene, Exigent	Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma	01/26	01/28
Matson, Melanie
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Guerra, Laura T
Dauntless-1, NCT04115306: Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer	Recruiting	1/2	61	US	PMD-026, fulvestrant, Faslodex	Phoenix Molecular Designs	Metastatic Breast Cancer	12/25	03/26
BEGIN, NCT06272864: BostonGene and Exigent Genomic INsight Study	Recruiting	N/A	400	US		BostonGene, Exigent	Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma	01/26	01/28
Matson, Melanie
No trials found